M. Spitz

998 total citations
31 papers, 827 citations indexed

About

M. Spitz is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, M. Spitz has authored 31 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in M. Spitz's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Viral Infections and Immunology Research (9 papers) and Glycosylation and Glycoproteins Research (6 papers). M. Spitz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Viral Infections and Immunology Research (9 papers) and Glycosylation and Glycoproteins Research (6 papers). M. Spitz collaborates with scholars based in United Kingdom, Argentina and Mexico. M. Spitz's co-authors include Robin Thorpe, Philip D. Minor, G. C. Schild, Michael A. J. Ferguson, Elsie M. Eugui, D. I. Magrath, Carlos A. Fossati, Carlos A. Velikovsky, Juliana Cassataro and Glyn Stanway and has published in prestigious journals such as Nature, The Lancet and Clinical Infectious Diseases.

In The Last Decade

M. Spitz

30 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Spitz United Kingdom 17 311 300 238 194 175 31 827
Sven‐Eric Svehag United States 13 172 0.6× 77 0.3× 136 0.6× 137 0.7× 193 1.1× 25 682
Rosario Guinea Spain 14 277 0.9× 169 0.6× 119 0.5× 366 1.9× 237 1.4× 14 940
Anthony E. Castro United States 20 201 0.6× 85 0.3× 33 0.1× 401 2.1× 155 0.9× 71 1.3k
R. V. Gilden United States 17 365 1.2× 48 0.2× 27 0.1× 181 0.9× 281 1.6× 38 1.1k
M. Denyer United Kingdom 16 283 0.9× 414 1.4× 39 0.2× 226 1.2× 357 2.0× 32 1.3k
Helmi Fijten Netherlands 14 229 0.7× 94 0.3× 158 0.7× 152 0.8× 115 0.7× 18 599
Silvia A. González Argentina 20 229 0.7× 148 0.5× 35 0.1× 497 2.6× 86 0.5× 54 1.1k
Ramón A. González Mexico 19 493 1.6× 109 0.4× 73 0.3× 301 1.6× 229 1.3× 42 1.1k
Kôsaku Fujiwara Japan 20 312 1.0× 48 0.2× 71 0.3× 591 3.0× 164 0.9× 136 1.5k
R. H. Meloen Netherlands 16 271 0.9× 68 0.2× 134 0.6× 249 1.3× 306 1.7× 27 923

Countries citing papers authored by M. Spitz

Since Specialization
Citations

This map shows the geographic impact of M. Spitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Spitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Spitz more than expected).

Fields of papers citing papers by M. Spitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Spitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Spitz. The network helps show where M. Spitz may publish in the future.

Co-authorship network of co-authors of M. Spitz

This figure shows the co-authorship network connecting the top 25 collaborators of M. Spitz. A scholar is included among the top collaborators of M. Spitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Spitz. M. Spitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cassataro, Juliana, Carlos A. Velikovsky, Guillermo H. Giambartolomei, et al.. (2002). Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA. Vaccine. 20(11-12). 1660–1669. 20 indexed citations
2.
Velikovsky, Carlos A., Juliana Cassataro, Guillermo H. Giambartolomei, et al.. (2002). A DNA Vaccine Encoding Lumazine Synthase fromBrucella abortusInduces Protective Immunity in BALB/c Mice. Infection and Immunity. 70(5). 2507–2511. 86 indexed citations
3.
Spitz, M.. (2000). Vacunas de ADN desnudo. Medicina-buenos Aires.
4.
Velikovsky, Carlos A., Juliana Cassataro, Mercedes Sanchez, et al.. (2000). Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Journal of Immunological Methods. 244(1-2). 1–7. 25 indexed citations
5.
Spitz, M., et al.. (1987). Studies on the human basophil IgE receptor generation and characterization of monoclonal antibodies against the receptor. Journal of Immunological Methods. 97(2). 185–190. 6 indexed citations
6.
Spitz, M.. (1986). [4] “Single-shot” intrasplenic immunization for the production of monoclonal antibodies. Methods in enzymology on CD-ROM/Methods in enzymology. 121. 33–41. 42 indexed citations
7.
Gearing, A. J. H., Robin Thorpe, Chris Bird, & M. Spitz. (1985). Human B cell proliferation is stimulated by interleukin 2. Immunology Letters. 9(2-3). 105–108. 19 indexed citations
8.
Spitz, M., et al.. (1985). Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytes.. PubMed. 54(3). 527–32. 12 indexed citations
10.
Thorpe, Robin, C.R. Bird, & M. Spitz. (1984). Immunoblotting with monoclonal antibodies: Loss of immunoreactivity with human immunoglobulins arises from polypeptide chain separation. Journal of Immunological Methods. 73(2). 259–265. 27 indexed citations
11.
Ferguson, Michael A. J., P. D. Minor, D. I. Magrath, M. Spitz, & G. C. Schild. (1984). Antigenic Characterization of Poliovirus Type 3 Using Monoclonal Antibodies. Clinical Infectious Diseases. 6(Supplement_2). S510–S513. 4 indexed citations
12.
Almond, Jeffrey W., Glyn Stanway, Alan J. Cann, et al.. (1984). New poliovirus vaccines: a molecular approach☆. Vaccine. 2(3). 177–184. 22 indexed citations
13.
Ferguson, Michael A. J., et al.. (1984). Neutralization Epitopes on Poliovirus Type 3 Particles: an Analysis Using Monoclonal Antibodies. Journal of General Virology. 65(1). 197–201. 43 indexed citations
14.
Minor, Philip D., G. C. Schild, Janet S. Bootman, et al.. (1983). Location and primary structure of a major antigenic site for poliovirus neutralization. Nature. 301(5902). 674–679. 156 indexed citations
15.
Ferguson, Morag, et al.. (1982). MONOCLONAL ANTIBODIES SPECIFIC FOR THE SABIN VACCINE STRAIN OF POLIOVIRUS 3. The Lancet. 320(8290). 122–124. 35 indexed citations
16.
Minor, Philip D., G. C. Schild, Michael A. J. Ferguson, et al.. (1982). Genetic and Antigenic Variation in Type 3 Polioviruses: Characterization of Strains by Monoclonal Antibodies and T1 Oligonucleotide Mapping. Journal of General Virology. 61(2). 167–176. 49 indexed citations
17.
Ferguson, Michael A. J., G. C. Schild, Philip D. Minor, Phil Yates, & M. Spitz. (1981). A Hybridoma Cell Line Secreting Antibody to Poliovirus Type 3 D-Antigen: Detection in Virus Harvest of Two D-Antigen Populations. Journal of General Virology. 54(2). 437–442. 16 indexed citations
18.
Gaffney, Patrick J., et al.. (1980). A novel radioimmunometric approach to the assay of components of human haemostasis: 1. Assay of plasma fibrinopeptide a levels. Thrombosis Research. 19(6). 815–822. 4 indexed citations
19.
Spitz, M., Leonardo Fainboim, & A. van Leeuwen. (1980). A NEW GENETIC MARKER OF HUMAN T LYMPHOID CELLS DETECTED BY A XENOGENIC MONOCLONAL ANTIBODY. International Journal of Immunogenetics. 7(4). 307–313. 2 indexed citations
20.
Spitz, M.. (1964). Immunoelectrophoretic Pattern of Phytohæmagglutinin. Nature. 202(4935). 902–902. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026